The proportion of “normal” profiles using three biomarkers (i.e., low p‐tau217/low NfL/low GFAP) was slightly lower in bvFTD (40%, compared to 47% low p‐tau217/low NfL profiles). The gene discussed is GFAP; the disease is behavioral variant of frontotemporal dementia.